Press Release
The French Atlas Copco subsidiary Exlair S.A.S has acquired Air et Techniques Energies Provence (ATEP), a distributor of industrial compressors and related products based in Aix-en-Provence, France.
Electrolux today issued a SEK 500m bond loan under its EMTN (Euro Medium Term Note) program.
Vejle Hospital and Odense University Hospital acquire Elekta treatment systems equipped with Elekta’s Agility MLC
Meda has signed an agreement with the U.S. company, Jazz Pharmaceuticals to acquire a portfolio of 6 pharmaceutical products focused on Women’s Health.
This is a correction of the press release sent September 4, 2012, 10:25, which stated the wrong number of preference shares that will be converted.
Alfa Laval has won an order to supply fresh water generators and diesel oil purifiers to major offshore platforms in Brazil.
The allocation of shares in Swedbank AB (”Swedbank”) has changed due to owners of preference shares having requested during the month of August, 2012 conversion of an aggregate of 8,266,802 preference shares into ordinary shares pursuant to the conversion clause set forth in Swedbank’s articles of association.
From 1st of January 2013 H&M Group puts a global ban on Perfluorinated Compounds (PFC:s). This means that all orders placed 1st of January 2013 or later will be produced without PFC:s.
Elekta has won a major contract related to the development of cancer treatment in the Chinese Army, People's Liberation Army, which operates the Army's military hospital.
Diamyd Medical reports results from Phase II study in cancer pain Tuesday, 03 July 2012
Diamyd Medical AB reports that a Phase II study evaluating the Company’s drug candidate NP2 Enkephalin did not meet its primary objective of reducing pain in subjects with severe intractable cancer pain. The treatment was however well tolerated, confirming the safety of the Company’s NTDDS technology.
The Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding marketing authorization of Zyclara (treatment of actinic keratoses on large skin areas).
Alfa Laval has won an order from a Technip Samsung Consortium (TSC) to supply Alfa Laval equipment to Shell’s Prelude FLNG (floating liquefied natural gas) facility. Alfa Laval is unable to disclose the exact value of the order due to a confidentiality agreement.
Advertisement
Business News Videos
Business News Videos
Atlas Copco acquires French compressor distributor
Thursday, 28 February 2013The French Atlas Copco subsidiary Exlair S.A.S has acquired Air et Techniques Energies Provence (ATEP), a distributor of industrial compressors and related products based in Aix-en-Provence, France.
Electrolux issues bond loan
Tuesday, 20 November 2012Electrolux today issued a SEK 500m bond loan under its EMTN (Euro Medium Term Note) program.
Danish Clinics Anticipate Benefits for Cancer Patients with Elekta’s Innovative Beam-shaping Solution for Radiotherapy
ODENSE and VEJLE, Denmark, Oct. 8, 2012Vejle Hospital and Odense University Hospital acquire Elekta treatment systems equipped with Elekta’s Agility MLC
Meda acquires Women’s Health products in the U.S
Thursday, 06 September 2012Meda has signed an agreement with the U.S. company, Jazz Pharmaceuticals to acquire a portfolio of 6 pharmaceutical products focused on Women’s Health.
Correction: Change of the distribution of shares in Swedbank due to conversion of preference shares to ordinary shares
Tuesday, 04 September 2012This is a correction of the press release sent September 4, 2012, 10:25, which stated the wrong number of preference shares that will be converted.
Alfa Laval to supply equipment worth SEK 85 million to platforms offshore Brazil
Tuesday, 04 September 2012Alfa Laval has won an order to supply fresh water generators and diesel oil purifiers to major offshore platforms in Brazil.
Change of the distribution of shares in Swedbank due to conversion of preference shares to ordinary shares
Tuesday, 04 September 2012The allocation of shares in Swedbank AB (”Swedbank”) has changed due to owners of preference shares having requested during the month of August, 2012 conversion of an aggregate of 8,266,802 preference shares into ordinary shares pursuant to the conversion clause set forth in Swedbank’s articles of association.
H&M puts ban on Perflourinated Compounds (PFC:s)
Tuesday, 04 September 2012From 1st of January 2013 H&M Group puts a global ban on Perfluorinated Compounds (PFC:s). This means that all orders placed 1st of January 2013 or later will be produced without PFC:s.
Elekta wins USD 35 million tender in China with its army
Thursday, 30 August 2012Elekta has won a major contract related to the development of cancer treatment in the Chinese Army, People's Liberation Army, which operates the Army's military hospital.
Diamyd Medical reports results from Phase II study in cancer pain Tuesday, 03 July 2012
Diamyd Medical AB reports that a Phase II study evaluating the Company’s drug candidate NP2 Enkephalin did not meet its primary objective of reducing pain in subjects with severe intractable cancer pain. The treatment was however well tolerated, confirming the safety of the Company’s NTDDS technology.
Positive outcome for Aerocrine in patent proceedings against Medisoft in Belgium
SOLNA,
Sweden - 29 June, 2012
Aerocrine
AB (OMX Nordic Exchange: AERO) today announced the positive outcome of
its complaint against Medisoft S.A. filed at the Liège Commercial
Court, Belgium.
Committee for Human Medicinal Products in the European Union gives Zyclara the positive nod
Monday, 25 June 2012The Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding marketing authorization of Zyclara (treatment of actinic keratoses on large skin areas).
Alfa Laval wins order to supply equipment for the world’s first FLNG facility
Friday, 01 June 2012Alfa Laval has won an order from a Technip Samsung Consortium (TSC) to supply Alfa Laval equipment to Shell’s Prelude FLNG (floating liquefied natural gas) facility. Alfa Laval is unable to disclose the exact value of the order due to a confidentiality agreement.